Pilaralisib analogue
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-11105-5MG | 5 mg | 95,00 | Add | |
| HY-11105-10MG | 10 mg | 140,00 | Add | |
| HY-11105-1ML | 10mM/1mL | 153,00 | Add | |
| HY-11105-50MG | 50 mg | 368,00 | Add | |
| HY-11105-100MG | 100 mg | 621,00 | Add | |
| HY-11105-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Pilaralisib analogue (XL147 analogue) is a representative and selective PI3Kα inhibitor extracted from patent WO2012006552A1, Compound 147 in Table 1.
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Apoptosis,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : ≥ 50 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 99.67% |
| Molecular Formula | C21H16N6O2S2 |
| Molecular Weight | 448.52 |
| CAS-Number | 956958-53-5 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
